Boundless Bio, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending December 31, 2024: USD 1.09 M

Boundless Bio, Inc. Depreciation And Amortization is USD 1.09 M for the Trailing 12 Months (TTM) ending December 31, 2024, a 13.48% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Boundless Bio, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending December 31, 2023 was USD 957.00 K.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased